This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Drossman DA et al. (Eds; 2000) Rome II: Functional gastrointestinal disorders. Diagnosis, pathophysiology, and treatment—A multinational consensus. 2nd ed. McLean, VA: Degnon Associates
Chiba N et al. (2003) The Rome II definition of dyspepsia does not exclude patients with GERD in primary care [abstract #1572] Gastroenterol 124 (Suppl 2): 223–224
Dent J et al. (2004) Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 53 (Suppl 4): S1–S24
van Pinxteren B et al. (2004) Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. The Cochrane Database of Systematic Reviews, Issue 3, Art. No CD002095.pub2
Mason JM et al. (2005) North of England Dyspepsia Guideline Development Group. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther 21: 1135–1143
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
BC Delaney has received speaker's honoraria from Astra Zeneca, Wyeth, Takeda, AxCan and Beckitt-Benkiser.
Rights and permissions
About this article
Cite this article
Delaney, B. What is the best initial therapy for patients with uninvestigated heartburn?. Nat Rev Gastroenterol Hepatol 2, 394–395 (2005). https://doi.org/10.1038/ncpgasthep0262
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0262